Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Rinsulin NPH vs Humulin NPH in Healthy Volunteers
NCT04501250Phase 1Completed
- Sponsor
- Geropharm
- Start
- Oct 2017
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin isophane in diabetes mellitus (DM) (2 arms), sponsored by Geropharm. Primary endpoints: Maximum Observed Plasma Concentration at 24 hours, Area Under the Concentration-Time Curve 0-12h and 5 more. Started Oct 2017; status: completed.
02
Drugs
insulin isophane
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT04501250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501250.